LataMed AI Begins Preliminary Expansion into Colombia

LataMed AI Corp. has initiated due diligence and strategic planning for market entry into Colombia, aiming to extend its digital healthcare platform in Latin America.

LA Metrowire Staff
Technology
LataMed AI Begins Preliminary Expansion into Colombia

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has commenced preliminary due diligence and strategic planning for expansion into Colombia. The company stated that the initial phase includes evaluating corporate, regulatory, legal, operational, and commercial requirements for establishing a Colombian operating subsidiary and deploying its digital healthcare platform in the market.

Management believes Colombia represents a strategic opportunity as part of its broader Latin American expansion strategy. The ongoing review will assess corporate formation, regulatory compliance, healthcare technology implementation, strategic partnerships, and local operational infrastructure necessary to support future operations. The evaluation aims to build upon the company's growing healthcare ecosystem by identifying opportunities to expand access to telehealth, care coordination, digital health services, insurance accessibility, pharmacy integration, payment solutions, and artificial intelligence-driven technologies across additional Latin American markets.

LataMed AI focuses on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets. Dr. Kevin Rodan Levy, CEO, stated: “Colombia represents an important strategic opportunity as we continue executing our long-term vision of building an integrated digital healthcare ecosystem across Latin America. While we remain in the early stages of evaluating market entry requirements, we believe it is important to establish the proper legal, operational, and strategic foundation before expanding into new jurisdictions.”

The company emphasized that the expansion remains in preliminary planning and due diligence. Management intends to complete corporate, regulatory, and operational reviews before establishing a Colombian subsidiary and expects to provide updates as developments occur. For additional information, visit https://latamed.ai or review filings with the SEC at www.sec.gov.

This expansion highlights the growing importance of digital health infrastructure in underserved markets, with potential implications for healthcare accessibility, patient engagement, and technology-enabled delivery in Latin America. LataMed AI's efforts could serve as a model for deploying AI and telehealth solutions in emerging economies facing healthcare access challenges.

Blockchain Registration

QR Code for Blockchain Registration